Cao; Jingtai
Patent Applications and Registrations
Patent applications and USPTO patent grants for Cao; Jingtai.The latest application filed is for "humanized c5 animals".
- Cao; Jingtai - White Plains NY
- CAO; Jingtai - Tarrytown NY
- Cao; Jingtai - Chappaqua NY
- Cao, Jingtai - Chappagua NY
| Patent | Date |
|---|---|
| Humanized C5 Animals App 20220132818 - Hu; Ying ; et al. | 2022-05-05 |
| Humanized C5 animals Grant 11,178,860 - Hu , et al. November 23, 2 | 2021-11-23 |
| Non-human Animals Models Of Retinoschisis App 20210307304 - Brydges; Susannah ; et al. | 2021-10-07 |
| Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors Grant 11,104,730 - Cao , et al. August 31, 2 | 2021-08-31 |
| Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab Grant 11,071,780 - Vitti , et al. July 27, 2 | 2021-07-27 |
| Non-human animal models of retinoschisis Grant 11,064,685 - Brydges , et al. July 20, 2 | 2021-07-20 |
| Humanized C5 Animals App 20200037587 - Hu; Ying ; et al. | 2020-02-06 |
| Humanized C3 animals Grant 10,524,458 - Hu , et al. J | 2020-01-07 |
| Humanized C5 animals Grant 10,492,477 - Hu , et al. De | 2019-12-03 |
| Methods And Formulations For Treating Vascular Eye Diseases App 20190117767 - VITTI; Robert L. ; et al. | 2019-04-25 |
| Humanized C3 Animals App 20180332833 - Hu; Ying ; et al. | 2018-11-22 |
| Non-human Animal Models Of Retinoschisis App 20180255754 - Brydges; Susannah ; et al. | 2018-09-13 |
| Methods of Treating Eye Disorders with APLNR Antagonists and VEGF Inhibitors App 20180251545 - CAO; Jingtai ; et al. | 2018-09-06 |
| Animal Model For Dry Eye And Methods Of Use Of Such Animals App 20170360013 - YUAN; Ming ; et al. | 2017-12-21 |
| Humanized C5 Animals App 20170332611 - Hu; Ying ; et al. | 2017-11-23 |
| Humanized C3 animals Grant 9,795,121 - Hu , et al. October 24, 2 | 2017-10-24 |
| Methods And Formulations For Treating Vascular Eye Diseases App 20170080086 - VITTI; Robert L. ; et al. | 2017-03-23 |
| Methods For Treating Dry Eye Disease By Administering An Il-6r Antagonist App 20160152717 - CAO; Jingtai ; et al. | 2016-06-02 |
| Methods And Formulations For Treating Vascular Eye Diseases App 20160144025 - VITTI; Robert L. ; et al. | 2016-05-26 |
| Humanized C5 And C3 Animals App 20150313194 - Hu; Ying ; et al. | 2015-11-05 |
| Ophthalmic composition of a VEGF antagonist Grant 7,531,173 - Wiegand , et al. May 12, 2 | 2009-05-12 |
| Methods of treating type I diabetes by blocking VEGF-mediated activity Grant 7,378,095 - Cao , et al. May 27, 2 | 2008-05-27 |
| Method of treating eye injury with local administration of a VEGF inhibitor App 20080085276 - Wiegand; Stanley J. ; et al. | 2008-04-10 |
| Method of treating eye injury with local administration of a VEGF inhibitor Grant 7,303,748 - Wiegand , et al. December 4, 2 | 2007-12-04 |
| Method of treating corneal transplant rejection Grant 7,300,653 - Wiegand , et al. November 27, 2 | 2007-11-27 |
| Method of treating corneal transplant rejection in high risk keratoplasty patients Grant 7,300,654 - Wiegand , et al. November 27, 2 | 2007-11-27 |
| Method of treating eye injury with local administration of a VEGF inhibitor App 20060172944 - Wiegand; Stanley J. ; et al. | 2006-08-03 |
| Methods of treating type I diabetes by blocking VEGF-mediated activity App 20060024309 - Cao; Jingtai ; et al. | 2006-02-02 |
| Method of treating corneal transplant rejection in high risk keratoplasty patients App 20050197291 - Wiegand, Stanley ; et al. | 2005-09-08 |
| Use of IL-1 blockers to prevent corneal inflammation and neovascularization App 20050129685 - Cao, Jingtai ; et al. | 2005-06-16 |
| Method of treating corneal transplant rejection App 20050004027 - Wiegand, Stanley ; et al. | 2005-01-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 